3HIKICHI T, OHTSUKA H, HIGUCHI M, et al. Causes of macular serous retinal detachments in Japanese patients 40 years and older [J]. Retina, 2009, 29(3) :396-404.
4MARKOMICHELAKIS N N, HALKIADAKIS I, PANTELIA E, et al. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography [J]. Ophthalmology, 2004,111 (5) : 946-953.
5GROVER S, APUSHKIN M A, FISHMAN G A, et al. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa [ J ]. Am J Ophthalmol, 2006, 141 ( 5 ) : 850-858.
6CANAKIS C, LIVIR-RALLATOS C, PANAYIOTIS Z, et al. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy[J]. Am J Ophthalmol, 2003,136(4) :750-752.
7YAMAGUCHI Y, OTANI T, KISHI S. Tomographie features of serous retinal detachment with muhilobular dye pooling in acute Vogt- Koyanagi-Harada disease [J].Am J Ophthalmol, 2007, 144 ( 2 ) : 260-265.
8HIRAKATA A, OKADA A A, HIDA T. Long-term results of vitrectomy without laser treatment for macular detachment associated with an optic disc pit [ J ]. Ophthalmology, 2005, 112 ( 8 ) : 1430-1435.
9BABA T, OHNO-MATSVI K, FUTAGAMI S, et al, Prevalence and characteristics of foveal retinal detachment without macular hole in high myopia[J]. Am J Ophthalmol, 2003, 135(3) : 338-342.
10KOBAYASHI H, KISHI S. Vitreous surgery for highly myopic eyes with foveal detachment and retinoschisis [ J ]. Ophthalmology,2003, 110(9) :1702-1707.
二级参考文献9
1Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema.Ophthalmology, 2002,109: 920-927.
2Park CH, Jaffe GL, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol, 2003,136: 419-425.
3The Central Vein Occlusion Study Group. Evaluation of grid laser pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology, 1995,102 : 1425-1433.
4McCuen BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamicinolone acetonide. Am J Ophthalmol, 1981,91: 785-788.
5Jonas JB. Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone 0il. Br J Ophthalmol, 2002,86:1450-1451.
6Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide afer triamcinolone-assisted vitreatomy. Am J Ophthalmol, 2003,135: 243-246.
7Moshfeghi DS, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol, 2003,136: 791-796.
8Schindler RH, Chandler D, Thresher R, et al. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol, 1982, 93:415-417.
9Beer PM, Bakri S J, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology, 2003,110: 681-685.
